[Treatment with immunocompetent cells and cellextracts (author's transl)].
The therapy of inborn or acquired defects of the cellular immune function is still in an experimental stage. Basicly, it is possible to replace the non-functioning T-cells by immunocompetent lymphocytes. Bone marrow, fetal liver and/or thymus, or cultivated thymus can serve as the source of such cells. Under certain conditions humoral factors derived from immunocompetent lymphocytes can induce a lacking immune response. Possibilities as well as limitations of these two therapeutic concepts are discussed.
D001854:Bone Marrow Cells; D002648:Child; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D008099:Liver / Q000166:cytology; D008214:Lymphocytes; D013947:Thymosin / Q000627:therapeutic use; D013950:Thymus Gland / Q000166:cytology; D014165:Transfer Factor / Q000627:therapeutic use
D014165:Transfer Factor; D013947:Thymosin
Behandlung mit immunologisch kompetenten Zellen und Zellextrakten.